...
search icon
eprx-img

Eupraxia Pharmaceuticals Inc. Common Stock, Common Stock

EPRX

NAQ

$3.94

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$139.10M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
11.00K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.43
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.2 L
$4.48 H
$3.94

About Eupraxia Pharmaceuticals Inc. Common Stock, Common Stock

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. The company's proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. Its lead product candidates include EP-104IAR, which is in Phase III clinical trial for the treatment of unmet medical needs and pain relief for knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameEPRXSectorS&P500
1-Week Return1.55%0.35%0.61%
1-Month Return-2.96%-0.91%6.14%
3-Month Return3.14%-10.83%3.5%
6-Month Return26.28%-7.74%-2.46%
1-Year Return48.12%-9%10.92%
3-Year Return33.56%2.52%44.02%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue116.81K111.53K193.27K209.91K-[{"date":"2020-12-31","value":55.65,"profit":true},{"date":"2021-12-31","value":53.13,"profit":true},{"date":"2022-12-31","value":92.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(116.81K)(111.53K)(193.27K)(209.91K)-[{"date":"2020-12-31","value":-11680900,"profit":false},{"date":"2021-12-31","value":-11152900,"profit":false},{"date":"2022-12-31","value":-19327300,"profit":false},{"date":"2023-12-31","value":-20991100,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)-[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses2.25M18.68M23.20M37.20M27.00M[{"date":"2020-12-31","value":6.04,"profit":true},{"date":"2021-12-31","value":50.22,"profit":true},{"date":"2022-12-31","value":62.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":72.6,"profit":true}]
Operating Income(2.25M)(20.87M)(22.63M)(37.20M)(27.00M)[{"date":"2020-12-31","value":-224576600,"profit":false},{"date":"2021-12-31","value":-2087242600,"profit":false},{"date":"2022-12-31","value":-2263460700,"profit":false},{"date":"2023-12-31","value":-3719539257,"profit":false},{"date":"2024-12-31","value":-2700341100,"profit":false}]
Total Non-Operating Income/Expense(3.24M)(6.43M)(615.12K)(1.44M)1.26M[{"date":"2020-12-31","value":-256.97,"profit":false},{"date":"2021-12-31","value":-509.66,"profit":false},{"date":"2022-12-31","value":-48.79,"profit":false},{"date":"2023-12-31","value":-114.43,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(4.01M)(23.37M)(23.92M)(38.33M)(25.74M)[{"date":"2020-12-31","value":-401063800,"profit":false},{"date":"2021-12-31","value":-2336955100,"profit":false},{"date":"2022-12-31","value":-2391721500,"profit":false},{"date":"2023-12-31","value":-3833082959,"profit":false},{"date":"2024-12-31","value":-2574268500,"profit":false}]
Income Taxes1.87M(1.34M)930.52K48.26K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-71.93,"profit":false},{"date":"2022-12-31","value":49.81,"profit":true},{"date":"2023-12-31","value":2.58,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(5.88M)(22.03M)(24.85M)(38.38M)-[{"date":"2020-12-31","value":-587883500,"profit":false},{"date":"2021-12-31","value":-2202581700,"profit":false},{"date":"2022-12-31","value":-2484773400,"profit":false},{"date":"2023-12-31","value":-3837908859,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(3.15M)(18.33M)(18.99M)(28.97M)(25.74M)[{"date":"2020-12-31","value":-314520374,"profit":false},{"date":"2021-12-31","value":-1832877210,"profit":false},{"date":"2022-12-31","value":-1899076400,"profit":false},{"date":"2023-12-31","value":-2896600600,"profit":false},{"date":"2024-12-31","value":-2574448900,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(4.00M)(22.99M)(23.26M)(37.39M)(25.50M)[{"date":"2020-12-31","value":-399720200,"profit":false},{"date":"2021-12-31","value":-2298960600,"profit":false},{"date":"2022-12-31","value":-2325937300,"profit":false},{"date":"2023-12-31","value":-3739170808,"profit":false},{"date":"2024-12-31","value":-2550253600,"profit":false}]
EPS (Diluted)----(0.23)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-23.36,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EPRX
Cash Ratio 12.48
Current Ratio 13.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EPRX
ROA (LTM) -52.06%
ROE (LTM) -116.77%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EPRX
Debt Ratio Lower is generally better. Negative is bad. 0.08
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.98

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EPRX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 80.15
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Eupraxia Pharmaceuticals Inc. Common Stock share price today?

Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) share price today is $3.94

Can Indians buy Eupraxia Pharmaceuticals Inc. Common Stock shares?

Yes, Indians can buy shares of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) on Vested. To buy Eupraxia Pharmaceuticals Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EPRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Eupraxia Pharmaceuticals Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) via the Vested app. You can start investing in Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) with a minimum investment of $1.

How to invest in Eupraxia Pharmaceuticals Inc. Common Stock shares from India?

You can invest in shares of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in EPRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Eupraxia Pharmaceuticals Inc. Common Stock shares
What is Eupraxia Pharmaceuticals Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is $4.48. The 52-week low price of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is $2.2.

What is Eupraxia Pharmaceuticals Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is 80.15

What is the Market Cap of Eupraxia Pharmaceuticals Inc. Common Stock?

The market capitalization of Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is $139.10M

What is Eupraxia Pharmaceuticals Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Eupraxia Pharmaceuticals Inc. Common Stock is EPRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top